Yahoo
NasdaqCM - Delayed Quote USD

HCW Biologics Inc. (HCWB)

1.1200 +0.0200 (+1.82%)
At close: 4:00:01 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
6,721.1860
54.2320
2,566.7920
2,841.7940
6,722.0900
Cost of Revenue
274.6200
43.3860
1,607.3890
2,281.4340
4,135.7120
Gross Profit
6,446.5660
10.8460
959.4030
560.3600
2,586.3780
Operating Expense
12,572.3530
11,268.1340
28,588.6190
26,277.5200
17,665.1560
Operating Income
-6,125.7870
-11,257.2880
-27,629.2160
-25,717.1600
-15,078.7780
Net Non Operating Interest Income Expense
-607.7530
-1,250.2730
-1,181.5880
-283.0420
-126.6600
Other Income Expense
1,481.8720
4,547.8520
-1,213.0100
1,005.9250
304.7350
Pretax Income
-5,251.6680
-7,959.7090
-30,023.8140
-24,994.2770
-14,900.7030
Net Income Common Stockholders
-21,410.1620
-22,298.7020
-30,023.8140
-24,994.2770
-14,900.7030
Diluted NI Available to Com Stockholders
-21,410.1620
-22,298.7020
-30,023.8140
-24,994.2770
-14,900.7030
Basic EPS
-16.62
-63.78
-184.80
-168.00
-100.80
Diluted EPS
-16.62
-63.78
-184.80
-168.00
-100.80
Basic Average Shares
787.5820
349.6160
161.6370
149.7060
149.2590
Diluted Average Shares
787.5820
349.6160
161.6370
149.7060
149.2590
Total Operating Income as Reported
-7,684.5270
-13,162.5100
-29,456.5200
-25,717.1600
-15,078.7780
Rent Expense Supplemental
166.3690
191.5980
205.5110
156.8070
132.7390
Total Expenses
12,846.9730
11,311.5200
30,196.0080
28,558.9540
21,800.8680
Net Income from Continuing & Discontinued Operation
-5,581.8540
-7,959.7090
-30,023.8140
-24,994.2770
-14,900.7030
Normalized Income
-19.7780
-5,922.3130
-30,023.8140
-24,994.2770
-14,900.7030
Interest Expense
607.7530
1,250.2730
1,181.5880
283.0420
126.6600
Net Interest Income
-607.7530
-1,250.2730
-1,181.5880
-283.0420
-126.6600
EBIT
-4,643.9150
-6,709.4360
-28,842.2260
-24,711.2350
-14,774.0430
EBITDA
-4,043.9260
-5,667.6650
-27,657.8370
-23,576.0510
-14,056.1890
Reconciled Cost of Revenue
274.6200
43.3860
677.4070
1,413.0130
3,756.3160
Reconciled Depreciation
599.9890
1,041.7710
1,184.3890
1,135.1840
717.8540
Net Income from Continuing Operation Net Minority Interest
-5,581.8540
-7,959.7090
-30,023.8140
-24,994.2770
-14,900.7030
Total Unusual Items Excluding Goodwill
-5,562.0760
-2,037.3960
0
-6,571.6890
--
Total Unusual Items
-5,562.0760
-2,037.3960
0
-6,571.6890
--
Normalized EBITDA
1,518.1500
-3,630.2690
-27,657.8370
-23,576.0510
-14,056.1890
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 7/20/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: